NCT05943379
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Peking University First Hosptital Beijing, Beijing Municipality, China
Clinical trial condition
Non-Muscle Invasive Bladder Neoplasms
Explore clinical trials studying Non-Muscle Invasive Bladder Neoplasms. Study availability and eligibility vary by location and protocol.
209 public trials
72 recruiting studies
Non-Muscle Invasive Bladder Neoplasms trial results
NCT05337397
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Aarhus University Hospital Aarhus, Denmark
Not yet recruiting
Trop2-Targeted Near-Infrared Fluorescence Imaging-Guided Precise Resection of Non-Muscle Invasive Bladder Cancer
NCT07800507
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Yunnan Cancer Hospital Kunming, Yunnan, China
Not yet recruiting
Precise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived Organoids
NCT06227065
- Conditions
- Bladder Cancer, Carcinoma, Female Urogenital Diseases, +15 more
- Locations
-
- Lindenhofspital, Klinik für Urologie Bern, Switzerland
- Spitalzentrum Biel, Klinik für Urologie Biel, Switzerland
Not yet recruiting
A Study to Evaluate the Efficacy and Safety of RAG-01 as Monotherapy and in Combination With Chemotherapy in Patients With Non-muscle Invasive Bladder Cancer (NMIBC).
NCT07777848
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Not yet recruiting
Feasibility of HISA During TURBT for NMIBC
NCT07817173
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy), Bladder Cancer, Bladder Cancer (BC), +20 more
- Locations
-
- Charleston Area Medical Center Memorial Hospital Charleston, West Virginia, United States
Not yet recruiting
Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study
NCT07189793
- Conditions
- Carcinoma, Carcinoma in Situ, Carcinoma in Situ of Bladder, +16 more
- Locations
-
- The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China
Not yet recruiting
Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT
NCT07808216
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
Not specified
Not yet recruiting
A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder Cancer
NCT07464145
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive), Carcinoma, +17 more
- Locations
-
Not specified
Not yet recruiting
Home-Based Supportive Care Program for NMIBC Patients Receiving Intravesical Perfusion: Construction and Preliminary Application
NCT07781956
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Nanjing First Hospital Nanjing, Jiangsu, China